NCT00000319View on ClinicalTrials.gov

Buprenorphine Maintenance Dose Schedule and Treatment Setting - 2

PHASE2CompletedINTERVENTIONAL
0
Timeline

Start Date

June 30, 1996

Study Completion Date

January 31, 2005

Conditions
Opioid-Related DisordersSubstance-Related Disorders
Interventions
DRUG

Buprenorphine

Trial Locations (1)

06519

APT Residential Services Division, New Haven

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Yale University

OTHER

NCT00000319 - Buprenorphine Maintenance Dose Schedule and Treatment Setting - 2 | Biotech Hunter | Biotech Hunter